MSI-H

Clinical trials for MSI-H explained in plain language.

Never miss a new study

Get alerted when new MSI-H trials appear

Sign up with your email to follow new studies for MSI-H, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New Two-Drug combo could extend lives in advanced stomach cancer

Disease control Recruiting now

This study is comparing a new two-drug immunotherapy combination (botensilimab + balstilimab) against standard chemotherapy plus immunotherapy for adults with advanced stomach or esophageal cancer that has specific genetic features. The main goal is to see if the new combination …

Matched conditions: MSI-H

Phase: PHASE3 • Sponsor: Centre Leon Berard • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

MSI-H

Get alerted when new MSI-H trials appear

New Two-Drug combo could extend lives in advanced stomach cancer